Introduction
To identify the appropriate action to take, an intelligent agent must infer the causal effects of every possible action choices. A prominent example is precision medicine, that attempts to identify which medical procedure (t ∈ T ) will benefit each individual patient (x) the most. This requires answering counterfactual questions (Rubin 1974; Pearl 2009 ) such as: "Would this patient have lived longer, had she received an alternative treatment?". There are several reasons why this is more challenging than conventional supervised machine learning:
First, for the i th patient, the training data only contains the observed outcome y ti i of the administered treatment t i but never the outcome(s) of the alternative treatment(s) ¬t i ∈ T \ {t i } -i.e., counterfactual outcome(s). This challenge can be mitigated if we are allowed to perform experimentation (on-line exploration), or have access to a randomized controlled trial (RCT) dataset (Pearl 2009 ). In many cases, however, conducting an experiment or RCT is expensive, impractical, or even infeasible. As a result, we are forced to approximate causal effects from data that is available: off-line datasets collected through observational studies. Such datasets, however, often exhibit sample selection bias (Imbens and Rubin 2015) . That is, the treatment t assignment procedure depends on some or all of the attributes x of the individual -i.e., Pr( t | x ) = Pr( t ). This becomes detrimental to the accuracy and confidence of counterfactuals prediction when the same covariates that determine treatment also [partially] determine the outcome y. Existence of such confounders is the second challenge with causal inference.
There are two categories of performance measures for evaluating causal inference methods. Population-based measures help find the one treatment that works [somewhat] well for the entire population. Individual-based measures, in contrast, focus on identifying the best treatment option personalized to each individual x. An example of individual-based measurethat requires estimating outcomes of all possible treatments -is Precision in Estimation of Heterogeneous Effect (Hill
, where e i = y . Here, to treat heart disease, a doctor prescribes surgery (t = 1) to younger patients (•) and medication (t = 0) to older ones (+) -hence we have sample selection bias. The unobservable counterfactuals are illustrated by small and faint • (for ¬t = 1) and + (for ¬t = 0).
Research Questions
In my PhD, I will explore ways to address the abovementioned challenges associated with causal effect estimation; with a focus on devising methods that enhance performance according to the individual-based measures. Specifically, my Research Questions (RQs) are the following:
1. The first challenge makes it impossible to properly evaluate the proposed methods with real-world observational datasets, since the ground truth for counterfactuals are in fact unobservable. Therefore, we require algorithms that can generate realistic synthetic observational datasets that exhibit various degrees of sample selection bias.
The remaining RQs are related to the second challenge:
2. Learning a representation space (Bengio et al. 2013 ) Φ, shared between treatment arms, is a good strategy to reduce sample selection bias. This is effective if distributions of the transformed instances Φ( x ) belonging to every treatment arm are similar -making the dataset close to an RCT. Reasonably, it should be possible to further alleviate the bias by incorporating appropriate weighting schemes.
3. Employ generative models to create new virtual samples that can fill in the gap in order to help better predicting the counterfactuals. Methods such as Variational AutoEncoder (Kingma and Welling 2014) and Generative Adverserial Network (Goodfellow et al. 2014) 4. Many observational datasets include censored instances.
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These instances should not be ignored as they might embed important information regarding the effectiveness of a certain treatment (e.g., a highly effective medication might make follow-up unlikely). We need survival prediction methods that can exploit censored data for achieving a higher performance in causal effect estimation.
5. Devise methods that accommodate counterfactual regression when more than two treatment options are availablei.e., (i) categorical (e.g., T = {bypass, stent, medication} for curing heart disease), (ii) multiple-binary (e.g., T = {0, 1} k -i.e., combination 2 of a subset of medications for controlling depression), or (iii) T ⊆ R (e.g., the right dosage of insulin for a diabetic patient).
Related Work
Learning treatment effects from observational studies is closely related to "off-policy learning in contextual bandits" and "learning from logged bandit feedback" (Swaminathan and Joachims 2015) . A common family of statistical methods use weighting to handle this sample selection bias. An example is Inverse Propensity Scoring (IPS), which tries to balance the source (observed) and target (counterfactual) distributions. Such methods however neglect the fact that controlling for the covariates that only determine the treatment (not outcome) 3 can have a negative impact on the accuracy of ITE predictions. Because the weights calculated according to such factors are irrelevant and perhaps detrimental to predicting accurate outcomes (both observed and counterfactual).
Another family of methods use representation learning to find a representation space Φ that reduces the sample selection bias between treatment arms. For example, Atan et al. (2018) learn Φ using an auto-encoder that tries to minimize the cross entropy loss between Pr( t ) and Pr( t | Φ( x ) ). However, by training an auto-encoder, they force their representation space to be able to reproduce all the covariates in x from Φ -some of which might have had no effect on determining the observed outcome. In another work, Shalit et al. (2017) learn Φ such that Pr( x | t = 0 ) and Pr( x | t = 1 ) are as close to each other as possible, provided that Φ( x ) retains enough information that a learned regression model h t ( Φ ) (with t being the administrated treatment) can generalize well on the observed outcomes. Neither of these methods, however, employ a context-aware weighting scheme to further alleviate the sample selection bias.
Research Plan
I have already addressed RQ#1 in (Hassanpour and Greiner 2018) and RQ#2 whose paper is in preparation; planned to be submitted to the IJCAI 2019. Table 1 summarized the tentative timeline for the remainder of my PhD program. 
